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Summary
We previously reported that the mice deficient for
SPA-1, a Rap1 GTPase-activating protein, developed
hematopoietic stem cell disorders. Here, we demon-
strate that SPA-12/2 mice show an age-dependent
increase in B220high B1a cells producing anti-dsDNA
antibody and lupus-like nephritis. SPA-12/2 peritoneal
B1 cells revealed the altered Vk gene repertoire, in-
cluding skewed Vk4 usage and the significant Igk/Igl
isotype inclusion indicative of extensive receptor
editing. Rap1GTP induced OcaB gene activation via
p38MAPK-dependent Creb phosphorylation, and con-
sistently, SPA-12/2 immature BM B cells showing high
Rap1GTP exhibited the augmented expression of
OcaB andVk4 genes. SPA-12/2BMcells could transfer
the autoimmunity in association with the generation of
peritoneal B220high B1a cells in Rag-22/2 recipients.
Finally, a portion of SPA-12/2 mice developed B1 cell
leukemia with hemolytic autoantibody. Present results
suggest that the regulated Rap1 signal in the immature
B cells plays a role inmodifying the B cell receptor rep-
ertoire and in maintaining the self-tolerance.
Introduction
Rap1 (Ras-proximity-1) is a member of the Ras family of
small G proteins ubiquitously expressed in most tissues
and mediates broad cellular activities. The Rap1 signal
plays an important role in controlling cell-cell and cell-
matrix adhesion by regulating integrins and other adhe-
sion molecules (Bos, 2005). It also regulates MAP ki-
nases, including ERK and p38MAPK, depending on the
cellular contexts and affects cell proliferation and sur-
vival, differentiation, and function (Stork, 2005). Rap1
is activated by a wide variety of stimuli, and this activa-
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Menlo Park, California 94025.tion is mediated by specific guanine nucleotide ex-
change factors (GEFs), such as C3G, which is recruited
by receptor-associated tyrosine kinases, and CalDAG-
GEF1 and Epacs, which are activatedby Ca2+/diacylglyc-
erol and cAMP, respectively (Bos, 2003). Rap1GTP, on
the other hand, is inactivated by Rap1 GTPase-activat-
ing proteins (GAPs), which control the magnitude, dura-
tion, and localization of Rap1 signaling (Mochizuki et al.,
2001). There are two groups of Rap1 GAPs, rapGAPs
and SPA-1 family proteins, each of which bears unique
protein interaction domains in addition to a conserved
catalytic domain and shows a distinct tissue expression
profile (Hattori and Minato, 2003).
Recent studies have begun to uncover the roles of the
Rap1 signal in the specific functional aspects of distinct
tissue cell types. It is essential in embryonic develop-
ment, and, thus, C3G deficiency results in the embryonic
lethality that is partly due to the defective integrity of ep-
ithelial cells (Ohba et al., 2001). In neurons, the Rap1 sig-
nal is involved in the development of neuronal polarity as
well as synaptic plasticity (Morozov et al., 2003; Pak
et al., 2001; Schwamborn and Puschel, 2004), and, in re-
nal tubular cells, the vasopression-regulated membrane
translocation of aqaporin-2 may be controlled by Rap1
(Noda et al., 2004). The Rap1 signal plays multiple roles
in hematopoietic cells (Kometani et al., 2004; Stork and
Dillon, 2005). For instance, CalDAG GEF1 deficiency
causes the insufficiency of platelet function leading to
the bleeding diathesis (Crittenden et al., 2004), while
SPA-1-deficient mice develop a spectrum of myelopro-
lifeartive stem cell disorders, including chronic myelog-
enous leukemia (CML) (Ishida et al., 2003a). Recent re-
ports also indicate the significant roles of the Rap1
signal in controlling the invasion and metastasis of can-
cers (Park et al., 2005; Yajnik et al., 2003).
Rap1 is a major activator of integrins in lymphocytes
and plays an important role in the immunological syn-
apse formation between T cells and antigen-presenting
cells (Katagiri et al., 2002; Sebzda et al., 2002) as well as
lymphocyte migration and trafficking (Katagiri et al.,
2004). On the other hand, a series of reports indicate
that Rap1 may mediate the negative signaling of T cell
activation in certain conditions (Boussiotis et al., 1997;
Katagiri et al., 2002). We showed that the increased
Rap1GTP in the antigen-primed T cells of SPA-12/2
mice resulted in the anergic state due to the interference
with T cell receptor (TCR)-mediated activation of the
Ras/ERK pathway (Ishida et al., 2003b). More recently,
it was reported that Rap1 played a role in the negative
signaling in T cells via CTLA-4 as well as the anergic
state of regulatory T cells (Dillon et al., 2005; Li et al.,
2005). Although Rap1 is also activated strongly in B cells
via B cell antigen receptor (BCR) stimulation (Christian
et al., 2003), its role in the B lineage cells remains to be
verified.
In the present study, we show that SPA-12/2mice de-
velop lupus-like autoimmune disease characterized by
an anti-dsDNA antibody and immune complex nephritis.
We provide evidence that deregulated Rap1 activation
in the immature BM B cells causes the altered IgL Vk
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418Figure 1. Age-Dependent Increase in B1a
Cells in SPA-12/2 Mice
(A) Representative profiles of the two-color
FACS analysis for the peritoneal cells from
control and SPA-12/2 mice at various ages
with the indicated antibodies. B1 cells are
marked by rectangles (proportions are
shown), and B2 cells are marked by circles.
(B) Total numbers of the peritoneal B1 cells
(B220+ Mac-1+), splenic follicular B cells
(CD23high CD21low), and marginal zone
(CD232 CD21high) B cells as well as the pro-
portions of B1a cells (B220+ CD5+) in the pe-
ripheral blood lymphocytes. The means and
SEs of the indicated numbers (n) of control
(open columns) and SPA-12/2 (solid col-
umns) mice of various ages are indicated.gene repertoire and ineffective receptor editing, leading
to the accumulation of self-reactive B1a cells in the peri-
toneal cavity, and we show that a portion of SPA-12/2
mice eventually develop B1 cell leukemia resembling
human chronic lymphocytic leukemia (CLL). The results
unveil a new aspect of the Rap1 signal linking B cell rep-
ertoire regulation, autoimmunity, and B1 cell leukemia.
Results
Age-Dependent Increase in the Peritoneal B220high
B1a Cells Accompanied by Anti-dsDNA Antibody
and Lupus-like Nephritis in SPA-1-Deficient Mice
SPA-12/2 mice showed an age-dependent increase in
the proportion of peritoneal B1 cells (IgMhigh B220+
CD232 CD21low), the majority of which exhibited CD5
expression, representing B1a cells (Figure 1A). It was
noted that the B1a cells of aged SPA-12/2 mice showed
homogenously higher intensity of B220 expression
(B220high) than control B1a cells, while Mac-1 expres-
sion tended to be lower (Figure 1A), the former feature
being shared with B1a cells of (NZBxNZW) F1 mice
with lupus (Figure S1; see the Supplemental Data avail-
able with this article online). The total B1 cell numbers in
SPA-12/2 mice were also increased in an age-depen-
dent manner, whereas the numbers of both follicular
(CD23high CD21low) and marginal zone (CD232 CD21high)
B cells in the spleens remained comparable to the con-
trol littermates (Figure 1B). Significant B1a cells were
also found in the circulation of SPA-12/2mice (Figure 1B
and Figure S2). The increased B1 cells showed no mor-
phological features of transformation (data not shown).
As shown in Figure 2A, SPA-12/2 mice showed signifi-
cant IgM anti-dsDNA antibody at as early as 3 months
of age, and many of them developed IgG, particularly
IgG2b and IgG3, as well as IgA anti-dsDNA antibodies
by 8 months of age. Also, about two-thirds ofSPA-12/2mice showed strong anti-nuclear and/or cyto-
plasmic antibodies (Figure 2B). Histological examination
revealed that the renal glomeruli in aged SPA-12/2 mice
were enlarged and had increased mesangial cells, re-
duced Bowman’s capsule space, and deposition of
IgM and C3, indicative of immune complex glomerulo-
nephritis (Figure 2C).
The Peritoneal B1 Cell Population in SPA-12/2 Mice
Includes dsDNA-Reactive B Cells and Cycles In Vivo
Freshly isolated peritoneal B1 cells of SPA-12/2 mice
showed marked increase in Rap1GTP, whereas splenic
B cells showed only a marginal increase (Figure 3A, left),
suggesting the constitutive activation of the former in
vivo. We therefore examined their cycling state in vivo
by feeding the mice with BrdU for 2 weeks. While few
peritoneal B1 cells incorporated BrdU in control mice,
as much as 17% of those in SPA-12/2mice were labeled
with BrdU, indicating that a significant proportion of the
SPA-12/2 B1 cells was cycling in vivo (Figure 3A, right).
In the culture, SPA-12/2 B1 cells showed a rather re-
duced proliferation response to anti-IgM plus anti-
CD40 antibodies, but LPS-induced proliferation was un-
affected, while SPA-12/2 spleen B cells proliferated in
response to both stimuli comparably with the controls
(Figure 3B). SPA-12/2 B1 cells apparently showed a
higher threshold for BCR stimulation than control B1
cells, and they required roughly five times more anti-
IgM to attain the equivalent proliferation (Figure S3).
Nonetheless, only SPA-12/2 B1cells showed significant
proliferation in response to dsDNA antigen in vitro (Fig-
ure 3B). Also, SPA-12/2 B1 cells produced two times
more IgM than control B1 cells by LPS stimulation, in-
cluding significant anti-dsDNA antibody (Figure 3C).
An elispot assay confirmed the presence of B cells
producing anti-dsDNA IgG in the peritoneal cells of
SPA-12/2 mice (data not shown). The results indicated
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419Figure 2. Development of Autoantibodies
and Immune Complex Nephritis in SPA-12/2
Mice
(A) Anti-dsDNA antibodies of various iso-
types in the sera (3100 dilution) from control
and SPA-12/2 mice at 3 and 8 months of age.
The bars indicate the mean values.
(B) Immunostaining of NIH3T3 cells (31000
magnification) with a control (wt) and
SPA-12/2 mouse (KO) sera (200:1 dilution).
(C) H&E staining (3400 magnification) and im-
munostaining with anti-IgM and anti-C3 anti-
bodies (31000 magnification) of the kidneys
from 8-month-old control and SPA-12/2
mice.that the dsDNA-reactive B cell clones were accumulated
preferentially in the peritoneal B1 cell population of
SPA-12/2 mice, and they suggested that clones were
activated by constitutive self-antigens in vivo despite
the apparently elevated threshold for the BCR-mediated
proliferation.
Biased Vk Gene Repertoire and Ig Light Chain
Isotypic Inclusion in the Peritoneal B1 Cells
of SPA-12/2 Mice
We then compared the BCR repertoires of B1 cells be-
tween SPA-12/2 and control mice by examining the Vk
gene usage. A total of 202 and 102 Vk gene cDNAs
were randomly cloned and sequenced from the purified
peritoneal B1 cells of four SPA-12/2 and three control lit-
termates of 8- to 10-month-old mice, respectively. Since
individual mice showed similar tendency, the results
were pooled. SPA-12/2 B1 cells showed a significantly
altered overall Vk gene repertoire as compared with the
control B1 cells, in which the frequency of Vk4 gene us-
age was markedly increased, reaching up to 40% (Fig-
ure 4, left). Unexpectedly, spleen B cells showed a largely
similar Vk gene repertoire to the B1 cells in SPA-12/2
mice, while the repertoire between B1 and B2 cell popu-
lations differed significantly in control mice, as expected
(Figure 4A, right). A distinct difference, however, wasfound between the B1 and B2 populations of SPA-12/2
mice. Thus, as much as 15% of the SPA-12/2B1 cells ex-
pressed both Igk and Igl chains, while few double ex-
pressers were detected in the splenic SPA-12/2 B cells
(Figure 4B). Similar results were obtained in the three
aged SPA-12/2mice, the mean proportion of double ex-
pressers in the peritoneal B cells being 11.3%. It was
noted that the Igkexpression levels of double expressers
were quite high (Figure 4B). In age-matched control
mice, the double expressers were negligible in both B
cell populations. The results strongly suggested that
SPA-12/2 mice showed a significantly altered Vk gene
repertoire shared by both B1 and B2 cell populations,
while only the former was enriched with the B cells that
had undergone apparently extensive receptor editing.
The Rap1 Signal Activates OcaB Gene Expression
via p38MAPK-Dependent Creb Phosphorylation
We pursued the molecular linkage between the deregu-
lated Rap1 signaling and the generation of self-reactive
B1 cells by using a SPA-12/2 mouse-derived cell line,
1629B, which showed characteristic features of B1a
cells (Figure S4A). While 1629B cells showed a high
Rap1GTP level, restoring the SPA-1 gene expression
abrogated the Rap1GTP accumulation. DNA microarray
analysis revealed that a B cell-specific gene, OcaB, was
Immunity
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1629B/SPA-1 cells (Figure S4B). The augmented OcaB
gene expression in 1629B cells was confirmed by both
Northern and immunoblotting (Figure 5A). The effect
was further confirmed in the WEHI231 B cell line bearing
a LoxP-flanked SPA-1 transgene, in that the induction of
SPA-1 by Cre-mediated recombination abrogated the
basal Rap1GTP and concomitantly suppressed the en-
dogenous OcaB expression (Figure 5A). While constitu-
tive IgM production was reduced in 1629B/SPA-1 cells,
the forced overexpression of OcaB resulted in signifi-
cant restoration (Figure 5A). A luciferase reporter assay
indicated that the expression of Rap1E63 (an active
form), but not Rap1N17 (an inactive form), enhanced
the promoter activity of a basic regulatory region of
the OcaB gene in both B (P3U1) and 293 cells, and the
effect was abolished by the cotransfection of SPA-1
(Figure 5B, left). C3G, a Rap1GEF, also strongly en-
hanced the promoter activity, indicating that the activa-
tion of endogenous Rap1 promoted OcaB gene tran-
Figure 3. B1 Cells Are Responsible for Autoantibody Production
and Cycle In Vivo in SPA-12/2 Mice
(A) Rap1GTP in the peritoneal B1 and spleen B cells from 8-month-
old control and SPA-12/2 mice was assessed by pull-down assay
(left). Peritoneal cells from control (gray line) and SPA-12/2 (black
line) mice fed with BrdU in their drinking water for 2 weeks were
stained with anti-BrdU, B220, and CD5 antibodies, and the propor-
tions of BrdU+ cells in the B1 cell fractions are indicated (right).
(B and C) Peritoneal B1 and spleen B cells from 8-month-old control
(open columns) and SPA-12/2 (solid columns) mice were cultured in
the absence or presence of anti-IgM plus anti-CD40 antibodies
(20 mg/ml each), LPS (100 mg/ml), or calf thymus dsDNA
(100 mg/ml) for 48 hr, and the proliferation response was assayed.
The means and SEs of four and seven mice, respectively, are shown.
The horizontal line indicates the response in the medium alone. Su-
pernatants of the cultures with or without LPS were harvested, and
total as well as anti-dsDNA IgM were determined by ELISA.scription. Rap1E63, however, failed to enhance the
activity of a promoter bearing a mutation in the Creb
binding site. Consistently, 1629B cells exhibited consti-
tutive phosphorylation of Creb (Figure 5B, right). They
also showed constitutive phosphorylation of both ERK
and p38MAPK, and they showed that the inhibition of
p38MAPK activation by a specific inhibitor without af-
fecting ERK resulted in the suppression of both Creb
phosphorylation and OcaB expression. The p38MAPK
inhibitor barely affected the high Rap1GTP level, sug-
gesting that Rap1was upstream of p38MAPK activation.
These results strongly suggested that Rap1GTP
promoted OcaB gene transcription via p38MAPK-
dependent Creb phosphorylation.
Augmented OcaB Expression in Peritoneal B1 Cells
and BM Immature B Cells with Enhanced Vk4 Gene
Expression of SPA-12/2 Mice
We then examined the expression of OcaB in the primary
B lineage cells of SPA-12/2mice. Both spleen B and peri-
toneal B1 cells from control mice only marginally ex-
hibited OcaB expression. In contrast, B1, but not spleen
B, cells of SPA-12/2 mice showed constitutive phos-
phorylation of p38MAPK and Creb and markedly aug-
mented expression of OcaB (Figure 5C, left) concomi-
tantly with the high Rap1GTP level (see Figure 3A).
RT-PCR analysis confirmed the increase in the OcaB
transcript in SPA-12/2 B1 cells (Figure 5C, center). In
the BM of SPA-12/2 mice, B lineage cells depleted of
IgDhigh mature B cells showed the accumulation of
Rap1GTP, and, again, this was associated with the en-
hanced phosphorylation of p38MAPK and Creb as well
as the augmented OcaB expression (Figure 5C, right).
SPA-12/2mice showed increased overall B lineage cells
(B220+), and this was mostly due to the increase in the
immature (IgM+ IgDlow) and some transitional (T1) B cells
(IgM+ CD212/low), with the total numbers of pro-/pre-B
cells being unchanged (Figure 5D, left). Furthermore,
RT-PCR analysis revealed that the immature SPA-12/2
BM B cells exhibited enhanced expression of Vk, partic-
ularly the Vk4 gene (Figure 5D, right). The results indi-
cated that Rap1-mediated OcaB upregulation paralleled
the increased BM immature B cells with a skewed Vk4
gene expression in SPA-12/2 mice.
Transplantation of SPA-12/2 BM Cells Results
in the Generation of Peritoneal B220high B1a Cells
and Anti-dsDNA Antibody in Rag-22/2 Recipients
To investigate whether the development of autoimmu-
nity was an autonomous feature of the SPA-12/2 BM
stem cells, we transplanted the BM cells, either total or
lin2, from SPA-12/2 and control mice into sublethally ir-
radiated Rag-22/2 mice. In the recipients of SPA-12/2
BM cells, irrespective of total or lin2 population, signifi-
cant anti-dsDNA IgG was detected from 3 months of
age onward, and 3 out of 5 recipients showed quite
high-titered anti-dsDNA IgG by 5 months of age (Fig-
ure 6A, left). While the peripheral leukocyte numbers
were slightly reduced in the recipients of SPA-12/2 BM
(Figure 6A, right), no hematologic abnormality was de-
tected (data not shown). In the peritoneal cavities of
the control BM recipients, very few B1a cells were gener-
ated (Figure 6B), and this is consistent with the previous
reports (Hayakawa and Hardy, 1988). On the other hand,
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421Figure 4. Altered Vk Gene Repertoire and
Igk/Igl Isotype Inclusion in the B1 Cells of
SPA-12/2 Mice
(A) Frequencies of the usage of Vk gene fam-
ilies in the peritoneal B1 cells and spleen B
cells of SPA-12/2 (solid columns) and control
(open columns) mice. A total of 202 and 102
Vk gene cDNA clones from the peritoneal B1
cells of four SPA-12/2 and three control
mice, respectively, and 137 and 142 cDNA
clones from the spleen B cells of three
SPA-12/2 and three control mice, respec-
tively, were sequenced.
(B) Peritoneal and spleen cells from
12-month-old control and SPA-12/2 mice
were analyzed with the indicated antibodies.
Proportions of Igk+ Igl2 and Igk+ Igl+ cells
are indicated. Similar results were obtained
in the analysis of three mice each.the recipients of SPA-12/2 BM, particularly those that
developed high-titered anti-dsDNA IgG, revealed the
significant generation of B1a cells in the peritoneal cav-
ity; essentially all of these B1a cells were B220high and
were similar to those in the donors (Figures 7B and 7C).
The results strongly suggested that the generation of
peritoneal B220high B1a cells and the development of
anti-dsDNA IgG antibody were SPA-12/2BM cell-auton-
omous.
Development of B1 Cell Leukemia with Hemolytic
Autoantibody Resembling Human B-CLL
While SPA-12/2 mice began to develop a spectrum of
hematologic disorders, including CML at ages over 12
months, a portion of them (9 out of a total of 62 leukemic
mice) were found to show a marked increase in circulat-
ing B cells (Figure 7A). They were highly homogenous,
medium-sized lymphoid cells with B220+ CD5+ Mac-1+
phenotypes typical for B1a cells (Figures 7B and 7C).
Southern blotting analysis of Ig JH-gene could be done
in three cases, and they were found to be oligo- or
monoclonal (data not shown). These mice showed
splenomegaly (the mean 430 mg versus 150 mg of the
control mice) and frequent lymphadenopathy, reminis-
cent of human B-CLL. A portion of them revealed
a marked increase in the highly blastic B1 cells through-
out the peritoneal cavity, spleen, lymph nodes, and
other vital organs, and the leukemia cells showed chro-
mosomal translocations, suggesting blastic progres-
sion (Figure S5). A hallmark of human B-CLL is the devel-
opment of autoantibodies, often causing autoimmune
hemolytic anemia. As shown in Figure 7D, sera from
six out of the nine mice showed significant hemolytic ac-
tivity, whereas none of the control or SPA-12/2mice with
CML did. The results suggested that B1a cells in
SPA-12/2 mice might be prone to leukemia.Discussion
We demonstrated here that mice deficient for SPA-1,
a negative regulator of the Rap1 signal, developed the
lupus-like autoimmune disease with occasional B1 cell
leukemia resembling human B-CLL. It was suggested
that the altered repertoire and ineffective receptor edit-
ing of Vk genes in the immature B cells underlie the dis-
ease, resulting in the generation of self-reactive B1 cells
and their self-antigen-driven expansion.
Expansion of dsDNA-Reactive B1 Cells
and Lupus-like Nephritis in SPA-1 Deficiency
SPA-12/2 mice revealed a progressive increase in peri-
toneal B1a cells as they aged, and this was accompa-
nied by the development of IgG anti-dsDNA and nuclear
antibodies. Primary SPA-12/2 B1 cells showed mark-
edly increased Rap1GTP, and a significant proportion
of them incorporated BrdU in vivo, indicating that they
were constitutively stimulated and cycling. Much higher
expression levels of B220 in the SPA-12/2B1a cells than
control counterparts might be consistent with constitu-
tive activation (Rice et al., 2005). The B1, but not spleen
B, cells of SPA-12/2 mice showed specific proliferation
in response to dsDNA and produced anti-dsDNA anti-
body by LPS stimulation in vitro. Interestingly, the
SPA-12/2 B1 cells showed a rather elevated threshold
for the BCR-mediated proliferation, while that for LPS
was unaffected. BCR-mediated, but not LPS-induced,
B cell proliferation was shown to depend crucially on
the Ras/ERK pathway (Coughlin et al., 2005), and thus
the effect was probably secondary to the high Rap1GTP
levels, which interfered with Ras-mediated ERK activa-
tion (Ishida et al., 2003b). Nonetheless, present results
strongly suggest the chronic expansion of self-reactive
Immunity
422Figure 5. OcaB Gene Activation by Rap1 Sig-
naling via p38MAPK-Dependent Creb Phos-
phorylation and Augmented OcaB Expres-
sion in the B1 and Immature BM B Cells of
SPA-12/2 Mice
(A) SPA-12/2 1629B cells infected with an
empty MIG (1629B/GFP) or MIG-SPA-1 retro-
virus (1629B/SPA-1) or WEHI231/loxP-SPA-1
B cells infected with an empty (Cre2) or Cre-
adenovirus (Cre+) were examined for the
expression of the OcaB mRNA by Northern
blotting and the indicated proteins by immu-
noblotting. Rap1GTP was assessed by pull-
down assay (left). 1629B/GFP (open col-
umns), 1629B/SPA-1 (closed columns), and
1629B/SPA-1 cells further transduced with
OcaB (gray columns) were cultured in the
presence of PA6 stroma cells for the indi-
cated periods, and IgM in the supernatants
was determined by ELISA (right).
(B) An OcaB promoter plasmid without (Wt) or
with (Mu) mutation in the Creb binding site
was cotransfected with an empty vector,
pSRa containing Rap1E63, Rap1N17,
SPA-1, or C3G cDNA into P3U1 myeloma or
293 cells. The doses of plasmids (mg) are indi-
cated in parentheses. Means and SEs of the
fold increases in luciferase activity normal-
ized for the transfection efficiency of the three
independent experiments are indicated (left).
1629B cells were cultured in the absence or
presence of a p38MAPK inhibitor (SB202190)
at the indicated concentrations, and the cell
extracts were subjected to immunoblotting
with the indicated antibodies or pull-down
assay for Rap1GTP (right).
(C) Lysates of the peritoneal B1 cells, spleen
B cells, and BM B lineage cells depleted of
the mature IgDhigh B cells from 10-month-
old control and SPA-12/2mice were immuno-
blotted with the indicated antibodies. RNAs
from the aliquots of the B1 cells were sub-
jected to RT-PCR analysis for OcaB and
GAPDH.
(D) BM cells from 12-month-old control and
SPA-12/2 mice were multicolor analyzed by
using the indicated antibody combinations.
Proportions of total B cells (B220+), pro- and pre-B cells (IgM2 B220+) in the B220+ cell gate, immature B cells (IgM+ IgD2/low) in the B220+
cell gate, and transitional B cells (T1; IgM+ CD212 and T2; IgMhigh CD21+) in the lymphoid cell gate are indicated (left). RNAs from the aliquots
of the immature BM B cells in (C) were subjected to RT-PCR analysis for the indicated genes (right).B1a cells by stimulation with constitutive and abundant
self-antigens in SPA-12/2 mice.
Age-dependent increase in the peritoneal B1 cells has
long been recognized in NZB and BWF1 mice (Haya-
kawa and Hardy, 1988). Their contribution to pathogenic
autoantibody production and lupus-like nephritis, how-
ever, remains controversial (Atencio et al., 2004; Balaba-
nian et al., 2003). Besides the natural lupus-prone mice,
a number of gene-targeted mutant mice were also re-
ported to develop anti-dsDNA/nuclear autoantibodies
with or without lupus-like nephritis. In many of those, in-
cluding CD222/2, FcgRIIB2/2, Aiolos2/2, and p21Cip12/2
mice, the autoimmunity was attributed to the general
hyperactivity of the B and/or T cells (O’Keefe et al.,
1999; Bolland and Ravetch, 2000; Sun et al., 2003;
Balomenos et al., 2000). Recently, mice with a loss-of-
function mutation in the RasGRP1 gene encoding
a Ras activator were shown to develop lupus-like auto-
immunity, in which autoantibody production was sec-ondary to the autoreactive T cells that emerged through
the defective thymic positive selection (Layer et al.,
2003). Although the possible contribution of T cells to
the autoimmunity in SPA-12/2 mice remains to be veri-
fied, our unpublished results indicate that the condi-
tional expression of the Rap1E63 transgene in the B line-
age cells also results in the development of anti-dsDNA
antibody (Y.K. and N.M., unpublished data). Thus,
SPA-12/2 mice provide a unique lupus model, in which
the generation of self-reactive B1 cells and their self-an-
tigen-driven expansion may play a primary role.
Altered Vk Repertoire and ‘‘Partial’’ Receptor Editing
in the Immature B Cells and Segregation of the
Self-Reactive B Cells to the Peritoneal Cavity
The B1 cell population in SPA-12/2 mice showed an al-
tered Vk gene repertoire compared with the control
counterpart, including a marked skewing for Vk4 gene
usage, and, rather unexpectedly, the feature was shared
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423Figure 6. Transfer of Autoimmunity into
Rag22/2 Mice by SPA-12/2 BM Cells
(A) BM cells, either total or lin2, of SPA-12/2
(solid circles) and age-matched control litter-
mates (open circles) were transplanted to the
4.5Gy X-ray-irradiated Rag22/2 mice, and
IgG anti-dsDNA in the sera was assessed at
the indicated periods (left). Peripheral leuko-
cyte counts of the control (open column)
and the SPA-12/2 BM recipients (solid col-
umn) at 4 months after the transplantation
are also indicated (right).
(B and C) FACS profiles of the peritoneal cells
of the control and SPA-12/2 BM recipients as
well as the representative original donor
mice. Total peritoneal cell numbers and pro-
portions of the B220high B1a cells are indi-
cated. Total numbers of the B220high B1a
cells in the recipients of control (open circles)
and SPA-12/2 (solid circles) BM were calcu-
lated. Double circles represent the recipients
with high-titered IgG anti-dsDNA shown in (A).with the SPA-12/2 spleen B cells. Because the immature
BM B cells also showed enhanced expression of the Vk4
gene, the characteristic Vk gene repertoire involving
both peripheral B cell populations was suggested to re-
flect the primary repertoire of the immature BM B cells. Adatabase analysis indicates that Vk4 is the most fre-
quently utilized Vk gene among anti-dsDNA and ANA
in mice (Liang et al., 2003), and, thus, enhanced Vk4
gene usage may favor the generation of immature B
cells reactive to the nuclear autoantigens. It was alsoFigure 7. B1 Cell Leukemia with Hemolytic
Autoantibody in SPA-12/2 Mice
(A) SPA-12/2mice with abnormal hemograms
were followed carefully and sacrificed when
they became moribund. Peripheral blood
was analyzed for the T (open area), B (dark
area), and myeloid (gray area) cells, and the
proportions of each fraction in the total leuko-
cytes are indicated. Means of ten control lit-
termates are also shown.
(B and C) Giemza staining (31000 magnifica-
tion) and the FACS profiles of the blood leu-
kocytes in a representative leukemic mouse
(#3209).
(D) Serially diluted sera from control,
SPA-12/2 mice with myeloid leukemia, and
SPA-12/2 mice with B1 leukemia were exam-
ined for the hemolytic activity.
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424found that high proportions of the B1 cells, but not the
spleen B cells, in aged SPA-12/2 mice were double
expressers of IgL k and l chains, indicative of extensive
receptor editing. It is indicated that a large proportion of
the preselective BCR repertoire in normal immature B
cells is self-reactive (Wardemann et al., 2003), and that
the receptor editing at the k locus plays an important
role in B cell tolerance for self-antigens (Chen et al.,
1997; Retter and Nemazee, 1998). While successful edi-
tion of the self-reactive BCR by rare editor Vks negates
self-reactivity, called ‘‘phenotypic exclusion,’’ rear-
rangement of Vk genes other than editor Vks may lead
to repetitive rearrangement, which, in turn, eventually
leads to the Vl gene rearrangement and expression
called ‘‘partial editing’’ (Kenny et al., 2000; Li et al.,
2001, 2002). Present results suggested that the
SPA-12/2 immature B cells tended to show ‘‘partial’’ ed-
iting of the self-reactive BCR, generating the potentially
self-reactive B cells. To support this, the transplantation
of SPA-12/2 BM cells into Rag-22/2 mice resulted in the
development of IgG anti-dsDNA antibodies concomi-
tantly with the generation of B220high peritoneal B1a
cells. The results suggested that the altered Vk gene
repertoire and ‘‘partial’’ receptor editing in the immature
B cells underlie the generation of self-reactive B cells in
SPA-12/2 mice.
In anti-dsDNA Ig transgenic mouse models, it was in-
dicated that the ‘‘partially’’ edited, potentially patho-
genic B cells expressing Igk/Igl dual receptors were
segregated to the spleen marginal zone (Li et al.,
2002). On the other hand, present results indicated
that the self-reactive B cells in SPA-12/2mice were seg-
regated to the peritoneal cavity, although their presence
in the marginal zone remained to be carefully examined.
The exact mechanisms for the segregation of self-reac-
tive B cells to the distinct privileged sites are unknown. It
was reported that the marginal zone B cells of NZB mice
exhibited enhanced b1-integrin expression (Atencio
et al., 2004), and we found that the peritoneal B1a cells
in SPA-12/2 mice also expressed much higher levels of
b1-integrin than follicular B cells (D.I. et al., unpublished
data). Since Rap1 controls the lymphocyte trafficking via
integrin activation (Katagiri et al., 2004), it may be possi-
ble that the sustained Rap1 activation in the self-reac-
tive SPA-12/2 B cells plays a role in their preferential
homing to the peritoneal cavity. Although we found sig-
nificant B1a cells in the circulation of aged SPA-12/2
mice, it remained to be investigated whether they repre-
sented the recirculating B1a cells or newly generated B1
cells homing to the peritoneal cavity.
Upregulation of OcaB Gene Expression
by the Deregulated Rap1 Signal in SPA-1 Deficiency:
A Possible Role in Autoimmunity
Present results revealed that the Rap1 signal potently
activated OcaB gene expression via p38MAPK-depen-
dent phosphorylation of its major transcription factor,
Creb (Stevens et al., 2000). While Rap1-mediated activa-
tion of p38MAPK and possibly Creb has been reported
in other cellular systems (Sawada et al., 2001; Schinelli
et al., 2001), this is one of the first indications that the
Rap1 signal mediates a gene activation specific for im-
mune function. Consistently, the peritoneal B1 and BM
immature B cells of SPA-12/2 mice, which showedhigh levels of Rap1GTP, exhibited constitutive
p38MAPK/Creb phosphorylation and augmented OcaB
expression. OcaB is a B cell-specific transcriptional co-
activator of Oct-1, 2 (Gstaiger et al., 1995; Luo and
Roeder, 1995; Strubin et al., 1995), and the expression
is tightly regulated during normal B cell development
(Qin et al., 1998). OcaB plays crucial roles at multiple
stages of B cell development, including early B cell de-
velopment, terminal maturation of the recirculating B
cells, and germinal center formation (Hess et al., 2001;
Kim et al., 1996; Nielsen et al., 1996; Schubart et al.,
1996). Most notably, OcaB is also crucial for the tran-
scription and recombination of a selective subset of Vk
genes, thus playing an important role in the modification
of the BCR repertoire and receptor editing (Casellas
et al., 2002). Among many Vk genes, Vk4 was reported
to be one of the most OcaB-dependent genes and is
highly editable in vivo when contributing to the self-
reactive BCR (Casellas et al., 2001, 2002). The skewed
expression of Vk in the immature SPA-12/2 B cells was
consistent with the augmented expression of OcaB.
We speculate that the excessive OcaB expression in
the self-reactive immature B cells of SPA-12/2mice pro-
motes the ‘‘partial’’ receptor editing of the BCR by virtue
of the selective preference for Vk genes other than editor
Vks; this preference eventually leads to the isotype in-
clusion. The increase in the immature BM B cells in
SPA-12/2 mice might, in part, reflect their prolonged
sojourn at the stage of receptor editing (Casellas et al.,
2001). This also raises an intriguing possibility that
Rap1 may normally mediate a ‘‘self-sensing’’ signal via
self-reactive BCR to initiate receptor editing via tran-
sient OcaB induction. Upregulated OcaB in the self-
reactive B cells may also facilitate their survival (Hess
et al., 2001). On the other hand, constitutive OcaB ex-
pression in the peripheral self-reactive B1 cells may
contribute to enhanced autoantibody production and
secretion. Interestingly, OcaB2/2 mice were also re-
ported to develop autoantibodies, which was associ-
ated with the accelerated cell death of the transitional
B cells (Jankovic and Nussenzweig, 2003). Thus, these
results suggest that the tight regulation of OcaB gene
expression by the Rap1 signal during B cell develop-
ment may be crucial for maintaining B-cell self-toler-
ance.
Possible Link between Autoimmunity and B1-Cell
Leukemia via the Rap1 Signal
It was found that a portion of SPA-12/2 mice eventually
developed leukemia of B1 cell origin. While the majority
of aged SPA-12/2 mice developed CML (Ishida et al.,
2003a), B1 cell leukemia was unlikely to represent the
lymphoid blast crisis of CML because it was not neces-
sarily preceded by overt CML. B1 cell leukemia was fre-
quently associated with the hemolytic autoantibody,
reminiscent of human B-CLL, which is suspected to
originate from B1 cells (Pangalis et al., 2002). Lupus-
prone mouse strains such as NZB/NZW and BWF1 also
frequently develop B1-type CLL and hemolytic autoanti-
body (Phillips et al., 1992). It was reported that the trans-
genic mice of TCL-1 and APRIL genes showed a selec-
tive increase in the peritoneal B1a cells, followed by
overt B-CLL, indicating that the aberrant activation of
certain protooncogenes could cause B1 cell leukemia
Rap1 Signal Controlling Autoimmunity
425(Bichi et al., 2002; Planelles et al., 2004). In this aspect, it
is noted that a number of potential protooncogenes are
overexpressed in the SPA-12/2B1 cell line, implying that
the persistent Rap1 activation in the self-reactive B1
cells by constitutive self-antigen stimulation may pre-
dispose them to leukemia via activation of protoonco-
genes. Rap1 signaling thus may link autoimmunity and
B-CLL.
Experimental Procedures
SPA-1 Gene-Targeted Mice
SPA-12/2 mice (Ishida et al., 2003a) were backcrossed to C57Bl/6
mice over ten generations and routinely monitored by the hemogram
and Giemza staining of blood films. SPA-12/2 mice with no hemato-
logical abnormalities were used for the analysis, while those with
dubious hematological data were maintained until overt leukemia
developed. C57Bl/6, BW (NZB 3 NZW) F1, and B6 Rag-22/2 mice
were purchased from CLEA Japan, Inc., Japan, and all of the mice
were maintained in an SPF condition at the Animal Center of the
Kyoto University Medical School.
Cytofluorimetric Analysis
Cells were blocked with anti-FcgRIII antibody and stained with com-
binations of antibodies, followed by multicolor cytofluorimetric anal-
ysis with FACS Calibur (Beckton Dickinson). Antibodies used
included APC-conjugated anti-B220, FITC-anti-Mac-1, PE-anti-
CD5, biotin-anti-CD5, PE-anti-CD23, PE-anti-IgD, FITC-anti-IgM
(eBioScience), FITC-anti-Igl, PE-anti-Igk, FITC-anti-CD21, and
APC-streptoavidin (BD Pharmingen).
Cell Separations, Cell Cultures, and Lymphocyte
Activation Assay
Peritoneal B1 (B220+ CD5+) and spleen B (B200+) cells were isolated
with a cell sorter (FACS Vantage, Beckton Dickinson). To enrich im-
mature B cells, BM cells were incubated with the mixtures of PE-
conjugated anti-CD3, anti-Mac-1, anti-Gr-1, and anti-IgD, followed
by anti-PE magnetic beads, and the negative fraction was collected
by the AutoMax system (Meltenyl Biotech, Germany). The SPA-12/2
1629B cell line stably transfected with SPA-1 (1629B/SPA-1) or GFP
alone (1629B/GFP) by using pMSCV-IRES/GFP (MIG) retroviral vec-
tor was cultured with PA6 stroma cells in complete BXH2 medium
(Ishida et al., 2003a). 1629B/SPA-1 cells were further transduced
with the OcaB gene by using a pMSCV-IRES/NGFR (MIN) retroviral
vector containing Flag-tagged OcaB cDNA, and NGFR+ cells were
sorted. WEHI231 cells were transfected with Flag-SPA-1 cDNA in
a pCALNL expression vector, kindly provided by Dr. I. Saito, Tokyo
University, Tokyo, Japan, by electroporation and were selected in
G418-containing medium. To induce the SPA-1 expression, the cells
were infected with Cre-containing adenovirus 2 days before use. For
in vitro stimulation of lymphocytes, purified B cells were cultured in
complete RPMI 1640 medium at 105 cells/well in the absence or
presence of calf thymus double-stranded (ds) DNA (Sigma) at
100 mg/ml, anti-IgM plus anti-CD40 antibody at 20 mg/ml each, or
LPS at 100 mg/ml for 48 hr and pulsed with 10 mCi 3H-thymidine fol-
lowed by scintillation counting.
BrdU Labeling In Vivo
Mice were fed with BrdU (BD Bioscience) in their drinking water at
0.8 mg/ml for 2 weeks. Peritoneal B1 cells were fixed and perme-
alized by BD Cytofix/Cytoperm buffer (BD Bioscience) for 30 min
on ice, treated with 30 mg/ml DNase for 1 hr at 37ºC, and stained
with FITC-conjugated anti-BUdR (BD Bioscience).
Detection of Autoantibodies, Immunostaining, Karyotyping,
and Cell Transfer
Anti-dsDNA antibody was detected by using ELISA. Serially diluted
sera or culture supernatants were incubated in the immunoplates
(Nunc) precoated with 5 mg/ml cellulose-conjugated calf thymus
dsDNA (Sigma) followed by alkaline phosphatase-conjugated anti-
mouse Ig antibody specific for each isotype (Southern Bio Technol-
ogy Associates). Hemolytic antibody was detected by incubating
the serially diluted sera with a washed normal mouse RBC suspen-sion in 96-well round-bottom plates in the presence of rabbit com-
plement (Cedarlane Laboratories Ltd., Canada) for 1 hr. To detect
antinuclear antibodies, NIH3T3 cells were fixed in 3% formaldehyde,
permealized with 1% Triton X-100/PBS, blocked with 2% BSA, and
incubated with diluted sera for 30 min, followed by FITC-anti-IgM an-
tibody. Kidneys were either fixed in formaldehyde for hematoxylin
and eosin (HE) staining or snap frozen in OCT for immunostaining
with FITC-anti-IgM and anti-C3 antibodies (BD Bioscience). For
cell transfer study, either total (2 3 107/mouse) or lin2 BM cells
(53 105/mouse) were injected intravenously into 4.5 Gy X-ray-irradi-
ated Rag22/2 mice.
Pull-Down Assay and Immunoblotting
Immunoblotting was done as before by using anti-SPA-1 (Tsuka-
moto et al., 1999), anti-Rap1, anti-Bob1 (OcaB) (Santa Cruz), anti-
phospho-Creb, anti-phospho-p38MAPK, and anti-phospho-ERK
(Cell Signaling). Rap1GTP was detected by a RalGDS pull-down
assay as described before (Tsukamoto et al., 1999).
RT-PCR and Vk cDNA Cloning
Total RNAs were extracted with ISOGEN Reagent (Nippon Gene,
Toyama, Japan) and treated with DNaseI (Invitrogen BV, Carlsbad,
CA). The cDNAs were synthesized with reverse transcriptase Super-
Script III (Invitrogen BV) and amplified by using the Expand High
Fidelity PCR System (Roche Diagnostics GmbH, Mannheim, Ger-
many). Primer sequences were as follows: CD19, 50-CTATGAGAAC
GACTCCAACC-30 and 30-CTAGGTCGTCAGACTTATCC-50; univer-
sal Vk, 50-GGCTGCAGSTTCAGTGGCAGTGGRTCWGG-30 and 30-GT
CCTGATCAGTCCAACTGTTCAG-50; Vk4, 50-CTGCMTCTCYDGG
GGAGAAG-30 and 30-CCWRMYCCACTGCCWMTRAAG-50; VpreB,
50-CGTCTGTCCTGCTCATGCT-30 and 30-ACGGCACAGTAATACA
CAGCC-50; l5, 50-CTTGAGGGTCAATGAAGCTCAGAAGA-30 and
30-CTTGGGCTGACCTAGGATTG-50; OcaB, 50-GGGAACATTATGT
GCTGGCT-30 and 30-GTCCTGAAGGACTGGCTCTG-50. For Vk gene
usage analysis, cDNAs from purified peritoneal B1 and splenic B
cells were amplified with a universal Vk primer set, randomly cloned,
and sequenced.
Promoter Assay
A 1.5 kb long promoter region of the OcaB gene (Stevens et al., 2000)
was PCR amplified from murine genomic DNA and cloned into
a pGEM-T easy vector. The primer set was 50-GCCAGGAAGTTCA
GGGGTTGAGTCAT-30 and 30-TTTCCTCCCGTGGAACCACCG-50.
The promoter fragment was subcloned into SacI/XhoI sites of a
pGVB2 vector. Mutation was introduced to CREB/ATF consensus
binding sites (264 to257 bp, GATGACGT to GATCTGGT; the muta-
tion is underlined) by using a QuikChange Site-Directed Mutagene-
sis Kit (Stratagene). P3U1 or 293 cells were cotransfected with the
OcaB reporter plasmid and various cDNAs in a pMX vector by using
lipofectamineTM 2000 (Invitrogen). Cell extracts were harvested
24 hr after the transfection and were assayed for luciferase activity
by using a Dual-Luciferase Reporter Assay System (Promega). The
values of luciferase activity were normalized by cotransfection
with the pRT-TK reporter plasmid.
Supplemental Data
Supplemental Data including five figures are available at http://www.
immunity.com/cgi/content/full/24/4/417/DC1/.
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